We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

SARS-CoV-2 Variants Can Evade Antibodies That Neutralize Original Virus

News   Mar 08, 2021 | Original story from Washington University School of Medicine

 
SARS-CoV-2 Variants Can Evade Antibodies That Neutralize Original Virus

Physician assistant Philana Liang prepares a vial of COVID-19 vaccine on the Washington University Medical Campus. New research from Washington University School of Medicine in St. Louis has found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic, potentially undermining the effectiveness of vaccines and antibody-based drugs now being used to prevent or treat COVID-19. Credit: Matt Miller/Washington University.

 
 
Advertisement
 

RELATED ARTICLES

The Majority of Human Origins Stories Are Not Compatible With Known Fossils

News

A review looks at the major discoveries in hominin origins since Darwin's works and argues that fossil apes can inform us about essential aspects of ape and human evolution, including the nature of our last common ancestor.

READ MORE

Which Drugs Are Most Toxic to the Liver?

News

A new study provides insights on how hospitalized patients can develop liver injury from taking different drugs.

READ MORE

Determining Safe Drug Doses for Children

News

Aalto University researchers in collaboration with the pharmaceutical company Novartis have developed a method that makes better use of available data to help determine safe pediatric drug doses more quickly and with fewer observations.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE